Clinical Trials Insight: 700011460
Latest Information Update: 05 Aug 2019
Price :
$35 *
At a glance
- Drugs C 1311 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Antisoma; Xanthus Pharmaceuticals
- 03 Aug 2019 Status changed from not yet recruiting to completed.
- 20 Jan 2006 New trial record.